1. Zu den Ersten gehören

        Co-Founder / CEO (Precision Oncology Startup)

        Heidelberg

        ImmunoEdge

        Vollzeit56.000 €102.000 €

        Oreste Acuto (Oxford), a leading immunologist whose groundbreaking work in T-cell receptor signaling laid key foundations for modern cancer immunotherapy.

        Vor 2 Tagen veröffentlicht